Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Clinical trial NCT02859961 · COMPLETED
Trial details
- NCT number
- NCT02859961
- Sponsor
- CytoDyn, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-07
- Primary completion
- 2020-09-16
- Enrollment
- 562
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.